University of Cincinnati Medical Center/College of Medicine
Radiation Oncology residency · Cincinnati, OH · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of Cincinnati Medical Center's research in radiation oncology, which the program shares with other departments and affiliated hospitals.
About University of Cincinnati Medical Centerinstitution-wide radiation oncology research
Radiation Oncology publications from University of Cincinnati Medical Center + Baylor College of Medicine and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
338
works per year
14th of 47 radiation oncology residency programs
+7.4%
2-year growth
29th of 47 radiation oncology residency programs
25.6%
in top 10% of field (works before 2025)
11th of 47 radiation oncology residency programs
47.9%
cited above world average
9th of 47 radiation oncology residency programs
Works per year · * 2026 so far
Oncology · 1,262Radiology, Nuclear Medicine and Imaging · 386
Radiation Oncology research topics at University of Cincinnati Medical Center
Papers in the window; each links to the list on OpenAlex.
- Cancer Immunotherapy and Biomarkers 198
- CAR-T cell therapy research 190
- Pancreatic and Hepatic Oncology Research 108
- Glioma Diagnosis and Treatment 77
- Colorectal Cancer Screening and Detection 62
- Cutaneous Melanoma Detection and Management 58
- Cardiac Imaging and Diagnostics 56
- Cancer Cells and Metastasis 53
Most cited at University of Cincinnati Medical Center since 2024
All radiation oncology papers there on OpenAlex
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 498
- Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancersDavid Steffin et al. · Nature · 2024 · PubMed · cited 300
- Invasion and metastasis in cancer: molecular insights and therapeutic targetsYongxing Li et al. · Signal Transduction and Targeted Therapy · 2025 · PubMed · cited 278
- Proteogenomic characterization of small cell lung cancer identifies biological insights and subtype-specific therapeutic strategiesQian Liu et al. · Cell · 2024 · PubMed · cited 219
- Cancer drug-tolerant persister cells: from biological questions to clinical opportunitiesMariangela Russo et al. · Nature reviews. Cancer · 2024 · PubMed · cited 216
- Intratumoral immune triads are required for immunotherapy-mediated elimination of solid tumorsGabriel Espinosa-Carrasco et al. · Cancer Cell · 2024 · PubMed · cited 209
- Unanswered questions following reports of secondary malignancies after CAR-T cell therapyBruce L. Levine et al. · Nature Medicine · 2024 · PubMed · cited 205
- An atlas of epithelial cell states and plasticity in lung adenocarcinomaGuangchun Han et al. · Nature · 2024 · PubMed · cited 183
- Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Kayleigh Pavitra Bhangdia et al. · The Lancet Oncology · 2026 · PubMed · cited 174
- SARS-CoV-2 mRNA vaccines sensitize tumours to immune checkpoint blockadeAdam Grippin et al. · Nature · 2025 · PubMed · cited 151